Back to Search
Start Over
Shilpa Medicare launches generic axitinib to treat advanced renal cell carcinoma
- Source :
- PharmaBiz. July 1, 2020
- Publication Year :
- 2020
-
Abstract
- Byline: Our Bureau In continuation to its recent launches of three products in the cancer therapy, Lenvatinib 'Lenshil Dasatinib 'Dasashil' and Ibrutinib 'Ibrushil' in Indian market, Shilpa Medicare Limited launches [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.628199159